Stepping up asthma care: new test may replace treadmill
NCT ID NCT07357805
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a 6-minute stepper test is a valid and reliable way to measure exercise capacity in adults with asthma. 41 participants with well-controlled asthma performed the stepper test and a standard treadmill test. The goal was to see if the simpler stepper test could accurately reflect exercise ability.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If the stepper test proves valid, it could give doctors a simple, low-cost way to check exercise capacity in asthma patients without needing a full lab test.
- What could go wrong
- This is a small, completed study focused on measurement, not treatment. The test may not be accurate for all asthma patients or replace standard exercise tests.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
41 people
The number who actually took part.
- Started
-
Jun 2017
- Finished
-
Jan 2019
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Forty-one patients with asthma were included.
- Ages
-
18 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age \> 18 years * Diagnosis of asthma established according to the Global Initiative for Asthma (GINA) guidelines * Use of standard asthma pharmacological treatment, including: inhaled corticosteroids (ICS), low-dose ICS in combination with long-acting β₂-agonists (LABA), or mild to high doses of ICS in combination with LABA * Asthma Control Test (ACT) score ≥ 20 * Smoking history of ≤ 10 pack-years Exclusion Criteria: * Presence of a recent respiratory tract infection * Use of systemic corticosteroids within the past year * History of smoking * Previous or current malignancy * Presence of any medical condition that could affect functional exercise capacity * Presence of any psychiatric disorder
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Asthma are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Gazi University Faculty of Health Sciences Department of Cardiopulmonary Physiotherapy and Rehabilitation, Ankara, Çankaya 06490
Ankara, Çankaya, 06490, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple breath test cut asthma Flare-Ups?
- Breathing tests face off: can extra lung measurements improve asthma diagnosis?
- The carbon label on your inhaler: can it sway a Doctor's choice?
- Six biologics put to the test in Real-World asthma and COPD care
- Can a digital program help teens with chronic illnesses move to adult care?
- Why do some kids catch every cold? a 1,200-Child study hunts for immune clues